Financials data is unavailable for this security.
View more
Year on year ABVC Biopharma Inc had revenues fall -84.28% from 969.78k to 152.43k, though the company grew net income from a loss of 16.42m to a smaller loss of 10.52m.
Gross margin | -24.11% |
---|---|
Net profit margin | -8,762.13% |
Operating margin | -6,259.18% |
Return on assets | -99.79% |
---|---|
Return on equity | -287.44% |
Return on investment | -197.79% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at ABVC Biopharma Inc fell by 674.95k. Cash Flow from Financing totalled 3.92m or 2,570.99% of revenues. In addition the company used 4.24m for operations while cash used for investing totalled 360.19k.
Cash flow per share | -1.50 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.6882 |
---|---|
Tangible book value per share | 0.6882 |
More ▼
Balance sheet in USDView more
Current ratio | 0.3343 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.2175 |
---|---|
Total debt/total capital | 0.1873 |
More ▼